Line 747:
Line 747:
|
|
|
|
−
|
+
|Mixed Phenotype Acute Leukemia (MPAL) with t(9;22)(q34.1;q11.2); BCR-ABL1
|Tracy Tucker, PhD, FCCMG
|Tracy Tucker, PhD, FCCMG
|
|
Line 763:
Line 763:
|
|
|
|
−
|
+
|Mixed Phenotype Acute Leukemia (MPAL) with t(v;11q23.3); KMT2A Rearranged
|Tracy Tucker, PhD, FCCMG
|Tracy Tucker, PhD, FCCMG
|
|
Line 779:
Line 779:
|
|
|
|
−
|
+
|NEW (No Prior)
−
|
+
|NEW (No Prior)
−
|
+
|NEW (No Prior)
−
|
+
|NEW (No Prior)
−
|
+
|NEW (No Prior)
|-
|-
|[[HAEM5:Mixed-phenotype acute leukaemia, B/myeloid|Mixed-phenotype acute leukaemia, B/myeloid]]
|[[HAEM5:Mixed-phenotype acute leukaemia, B/myeloid|Mixed-phenotype acute leukaemia, B/myeloid]]
Line 795:
Line 795:
|
|
|
|
−
|
+
|Mixed Phenotype Acute Leukemia (MPAL), B/Myeloid, Not Otherwise Specified
|Priyatharsini Nirmalanantham, MD and Shashi Shetty, PhD
|Priyatharsini Nirmalanantham, MD and Shashi Shetty, PhD
|
|
Line 811:
Line 811:
|
|
|
|
−
|
+
|Mixed Phenotype Acute Leukemia (MPAL), T/Myeloid, Not Otherwise Specified
|Narsis Attar, MD, PhD, Fabiola Quintero-Rivera, MD University of California, Irvine
|Narsis Attar, MD, PhD, Fabiola Quintero-Rivera, MD University of California, Irvine
|
|
Line 827:
Line 827:
|
|
|
|
−
|
+
|Mixed-Phenotype Acute Leukemia, Not Otherwise Specified (NOS), Rare Types
|Elicia Goodale, MD, Medical University of South Carolina Daynna Wolff, PhD, Medical University of South Carolina
|Elicia Goodale, MD, Medical University of South Carolina Daynna Wolff, PhD, Medical University of South Carolina
|
|
Line 843:
Line 843:
|
|
|
|
−
|
+
|NEW (No Prior)
−
|
+
|NEW (No Prior)
−
|
+
|NEW (No Prior)
−
|
+
|NEW (No Prior)
−
|
+
|NEW (No Prior)
|-
|-
|[[HAEM5:Acute undifferentiated leukaemia|Acute undifferentiated leukaemia]]
|[[HAEM5:Acute undifferentiated leukaemia|Acute undifferentiated leukaemia]]
Line 859:
Line 859:
|
|
|
|
−
|
+
|Acute Undifferentiated Leukemia
|Amelia Nakanishi, MD and Shashi Shetty, PhD
|Amelia Nakanishi, MD and Shashi Shetty, PhD
|
|